Sophie graduated from the University of Leeds (MChem) with a placement involving research of an opioid addiction treatment drug and its impurities, in order for the drug to be approved. Sophie is currently working towards a PhD in the O'Brien, Parkin and Chechik groups. Her research involves the late-stage functionalisation of drug-like scaffolds by electrochemically-generated free radicals.